Hydrochlorothiazide NDC 63187-548

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-548Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0548Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-548-07	63187054807	7 CAPSULE, GELATIN COATED in 1 BOTTLE (63187-548-07)Marketed from May 1, 2017
63187-548-30	63187054830	30 CAPSULE, GELATIN COATED in 1 BOTTLE (63187-548-30)Marketed from May 1, 2017
63187-548-60	63187054860	60 CAPSULE, GELATIN COATED in 1 BOTTLE (63187-548-60)Marketed from May 1, 2017
63187-548-90	63187054890	90 CAPSULE, GELATIN COATED in 1 BOTTLE (63187-548-90)Marketed from May 1, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrochlorothiazide
Generic name (nonproprietary): hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1
Dosage form: Capsule, Gelatin coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020504
Marketing start: Dec 27, 1996
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 63187-548_75e914c5-6085-4f47-808b-f708657aa375SPL ID 75e914c5-6085-4f47-808b-f708657aa375SPL set ID c1052d38-fd75-40c2-a685-0e889009be0bRxCUI 199903UNII 0J48LPH2THUPC 0363187548902
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187054807 followed by a unit qualifier and the quantity

Package 63187-0548-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 1, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hydrochlorothiazide is indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors. Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. Edema durin…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020504

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020504
Product	Strength	Form · route	Labeler	Product NDC
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	Capsule, Gelatin coatedOral	Aphena Pharma Solutions - Tennessee, LLC	67544-739
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	Capsule, Gelatin coatedOral	Actavis Pharma, Inc.	0591-0347
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	Capsule, Gelatin coatedOral	QPharma, Inc.	42708-027